

(Sharecast News) - GSK announced on Thursday that its monoclonal antibody 'Nucala', or mepolizumab, delivered a statistically significant and clinical...


(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and on Wednesday:


(Alliance News) - London stocks were called to open higher on Thursday, ahead of the manufacturing purchasing managers' index read for the UK.


GSK PLC - London-based pharmaceutical maker - Says trial of Nucala, whose generic name is mepolizumab, shows positive results in the treatment of chro...


Smith+Nephew surges on affirming FY outlook despite potential tariff impact *


(Alliance News) - The FTSE 100 closed higher on Wednesday, as US markets fell after weak economic growth data.


(Sharecast News) - London stocks extended their gains on Wednesday, after fresh data from the US showed a slowing in consumer price growth, alongside ...